Jean Hoffman Joins MedRhythms’ Board of Directors
March 1st, 2017
Jean Hoffman has joined the Board of Directors of MedRhythms, a digital medicine startup that combines sensors, neuroscience, and music to help people recover from neurologic injury or disease. Led by Brian Harris, CEO, and Owen McCarthy, President, the company was launched at the end of 2014 and has been growing steadily since. Current partnerships include the Spaulding Rehabilitation Network, The Brain Injury Association of Massachusetts and Boston University Aphasia Resource Center.
Jean says she is impressed by the MedRhythms team. “I have been working with Brian and Owen for a few months and am impressed that both are A players who have the vision and ability to execute and overcome the many challenges that any early stage healthcare company faces. As founders, they’ve identified a market need, developed and filed a provisional patent for their first product, and laid out a thoughtful business foundation. Based on my own experience as an entrepreneur, I’m confident in the concept for MedRhythms and in Brian and Owen’s ability to lead the company to achieve that growth potential,” says Hoffman.
MedRhythms’ expects to seek FDA approval for its pioneer product, a medical device that uses sensors to collect patient performance data in order to individualize music therapy treatment. Neurologic music therapy can be used to treat Multiple Sclerosis, stroke, traumatic brain injury, Huntington’s disease, Parkinson’s disease, Alzheimer’s disease, cerebral palsy and the autism spectrum, among other neurologic injury and diseases.
Read full article in Mainebiz
